Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 16-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 9 of 9)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
22-Mar-14Wright ReportsN/AWright Investors Service Comprehensive Report for Cadence Pharmaceuticals, Inc.42$75  View Abstract
21-Mar-14Reuters Investment ProfileN/ACadence Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
21-Mar-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for CADX11$25  View Abstract
21-Mar-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CADENCE PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
17-Mar-14Zacks Investment Research Inc.N/ACADENCE PHARMA (CADX) Zacks Company Snapshot1$11.50  View Abstract
15-Mar-14S&P Capital IQ Quantitative ReportN/ACadence Pharmaceuticals11$126.50  View Abstract
14-Mar-14Ford Investor Services, Inc.N/AValue Graph: CADENCE PHARMA -- CADX1$11.50  View Abstract
28-Feb-14Zacks Investment Research Inc.N/ACADENCE PHARMA (CADX) Zacks Company Snapshot1$11.50  View Abstract
26-Feb-14Zacks Investment Research Inc.N/ACADENCE PHARMA (CADX) Zacks Company Snapshot1$11.50  View Abstract

Independent Reports (Showing 1 to 9 of 9)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
22-Mar-14Wright ReportsN/AWright Investors Service Comprehensive Report for Cadence Pharmaceuticals, Inc.42$75View Abstract
21-Mar-14Reuters Investment ProfileN/ACadence Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
21-Mar-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for CADX11$25View Abstract
21-Mar-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CADENCE PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
17-Mar-14Zacks Investment Research Inc.N/ACADENCE PHARMA (CADX) Zacks Company Snapshot1$11.50View Abstract
15-Mar-14S&P Capital IQ Quantitative ReportN/ACadence Pharmaceuticals11$126.50View Abstract
14-Mar-14Ford Investor Services, Inc.N/AValue Graph: CADENCE PHARMA -- CADX1$11.50View Abstract
28-Feb-14Zacks Investment Research Inc.N/ACADENCE PHARMA (CADX) Zacks Company Snapshot1$11.50View Abstract
26-Feb-14Zacks Investment Research Inc.N/ACADENCE PHARMA (CADX) Zacks Company Snapshot1$11.50View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.